{"id":"metronidazole-400-14-days","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Metallic taste"},{"rate":"10-15","effect":"Nausea"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Diarrhea"},{"rate":"5-10","effect":"Abdominal discomfort"},{"rate":"1-2","effect":"Peripheral neuropathy (with prolonged use)"},{"rate":"<1","effect":"Seizures (rare)"}]},"_chembl":null,"_fixedAt":"2026-03-30T17:40:59.463901","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug is activated by anaerobic organisms and parasites through enzymatic reduction of its 5-nitro group, producing reactive intermediates that damage DNA and prevent nucleic acid synthesis. This mechanism makes it effective against anaerobic bacteria and certain protozoan parasites. It is bactericidal and antiprotozoal in action.","oneSentence":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after reduction of its nitro group.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:55:05.578Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anaerobic bacterial infections"},{"name":"Trichomoniasis"},{"name":"Giardiasis"},{"name":"Amebiasis"},{"name":"Bacterial vaginosis"},{"name":"Clostridioides difficile infection"},{"name":"Peptic ulcer disease (as part of H. pylori eradication)"}]},"_fixedFields":["pubmed(79)"],"trialDetails":[{"nctId":"NCT07312721","phase":"PHASE4","title":"Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis","status":"COMPLETED","sponsor":"Azfar Farogh","startDate":"2024-01-05","conditions":"Helicobacter Pylori Infection, Chronic Gastritis, Peptic Ulcer Disease","enrollment":752},{"nctId":"NCT03304587","phase":"NA","title":"Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors","status":"COMPLETED","sponsor":"Michigan State University","startDate":"2017-11-06","conditions":"Breast Cancer","enrollment":30},{"nctId":"NCT06760065","phase":"PHASE3","title":"Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment","status":"NOT_YET_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-01-15","conditions":"Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education","enrollment":316},{"nctId":"NCT05462496","phase":"PHASE2","title":"Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2023-03-16","conditions":"Pancreatic Cancer","enrollment":25},{"nctId":"NCT05444218","phase":"NA","title":"Surgical Access Combined With Systematically Administered Antibiotics in the Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"University of Guarulhos","startDate":"2021-05-01","conditions":"Peri-Implantitis","enrollment":89},{"nctId":"NCT05383521","phase":"NA","title":"Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis","status":"NOT_YET_RECRUITING","sponsor":"Shangrong Fan","startDate":"2025-12-01","conditions":"Trichomonas Vaginitis","enrollment":20},{"nctId":"NCT06216639","phase":"","title":"Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection","status":"UNKNOWN","sponsor":"National Institute of Public Health, Slovenia","startDate":"2024-02-01","conditions":"Helicobacter Pylori Infection","enrollment":2000},{"nctId":"NCT06177119","phase":"NA","title":"Amoxicillin and Metronidazole During or After the Periodontal Treatment","status":"UNKNOWN","sponsor":"Belén Retamal-Valdes","startDate":"2012-01-31","conditions":"Periodontitis","enrollment":72},{"nctId":"NCT02373280","phase":"NA","title":"The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection","status":"UNKNOWN","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-08","conditions":"Helicobacter Infection","enrollment":600},{"nctId":"NCT02359331","phase":"NA","title":"The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection","status":"TERMINATED","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-08","conditions":"Helicobacter Infection","enrollment":370},{"nctId":"NCT03383120","phase":"NA","title":"Diode Laser for Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"University of Geneva, Switzerland","startDate":"2017-10-10","conditions":"Peri-Implantitis, Implant Complication","enrollment":40},{"nctId":"NCT04359966","phase":"NA","title":"Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia","status":"UNKNOWN","sponsor":"Slovenian Society for Gastroenterology and Hepatology","startDate":"2020-05-10","conditions":"Helicobacter Pylori Infection, Eradication Treatments","enrollment":560},{"nctId":"NCT02954393","phase":"NA","title":"Amoxicillin and Metronidazole During Periodontal Treatment","status":"UNKNOWN","sponsor":"Belén Retamal-Valdes","startDate":"2015-05","conditions":"Chronic Periodontitis","enrollment":180},{"nctId":"NCT03733379","phase":"PHASE3","title":"Systemic Probiotics in the Periodontal Treatment","status":"UNKNOWN","sponsor":"Belén Retamal-Valdes","startDate":"2018-11-05","conditions":"Periodontitis","enrollment":176},{"nctId":"NCT02735395","phase":"PHASE4","title":"Dose and Duration of Metronidazole and Amoxicillin for Treatment of Chronic Periodontitis","status":"UNKNOWN","sponsor":"University of Guarulhos","startDate":"2011-07","conditions":"Chronic Periodontitis","enrollment":110},{"nctId":"NCT03132714","phase":"PHASE2, PHASE3","title":"Periodontal Debridement Associated With Systemic Antibiotics and Single/Repeated PDT to Treat Aggressive Periodontitis","status":"COMPLETED","sponsor":"Universidade Estadual Paulista Júlio de Mesquita Filho","startDate":"2015-03","conditions":"Aggressive Periodontitis, Generalized","enrollment":46},{"nctId":"NCT02349685","phase":"NA","title":"The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2010-01","conditions":"Helicobacter Infection","enrollment":219},{"nctId":"NCT00683865","phase":"PHASE3","title":"Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-04","conditions":"Pelvic Inflammatory Disease","enrollment":749},{"nctId":"NCT00453349","phase":"PHASE3","title":"A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-01","conditions":"Pelvic Inflammatory Disease","enrollment":460},{"nctId":"NCT02135952","phase":"PHASE4","title":"Metronidazole and Amoxicillin for the Treatment of Type 2 Diabetic Subjects With Periodontitis","status":"UNKNOWN","sponsor":"University of Guarulhos","startDate":"2011-09","conditions":"Periodontitis","enrollment":58},{"nctId":"NCT01837199","phase":"PHASE4","title":"MTZ Plus AMX in the Treatment of Smokers and Non-smokers","status":"COMPLETED","sponsor":"University of Guarulhos","startDate":"2011-07","conditions":"Chronic Periodontitis, Smoking","enrollment":64}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":79,"recentPublications":[{"date":"2026 Jan 29","pmid":"41620038","title":"Vonoprazan-Tetracycline Dual Regimen as Rescue Therapy for Helicobacter pylori Infection: Randomized Controlled Trial.","journal":"Gastroenterology"},{"date":"2025 Dec 18","pmid":"41413744","title":"Concomitant versus reverse hybrid therapy for eradication of Helicobacter pylori infection-An open-label randomized controlled trial.","journal":"Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology"},{"date":"2025","pmid":"41245387","title":"Comparison of tegoprazan-based high-dose dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: a prospective, multicentre, randomised controlled trial in Gansu Province, a high-resistance region of China.","journal":"Therapeutic advances in gastroenterology"},{"date":"2026 Jan","pmid":"40945526","title":"Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial.","journal":"The Lancet. Infectious diseases"},{"date":"2025 Jul 28","pmid":"40867952","title":"Bismuth Quadruple Therapy with Doxycycline Is an Effective First-Line Therapy for Helicobacter pylori in an Irish Cohort.","journal":"Antibiotics (Basel, Switzerland)"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Metronidazole 400 (14 days)","genericName":"Metronidazole 400 (14 days)","companyName":"University of Guarulhos","companyId":"university-of-guarulhos","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after reduction of its nitro group. Used for Anaerobic bacterial infections, Trichomoniasis, Giardiasis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}